Stay updated on Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The Record History now shows a new revision entry 'Revision: v3.3.3'. The footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.
    Difference
    0.2%
    Check dated 2025-12-22T01:11:17.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.3.2 and the removal of v3.3.1 in the study's records, a routine site maintenance update that does not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T16:24:59.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    - Revision updated from v3.2.0 to v3.3.1 on the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-23T14:50:11.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Removed the banner about a lapse in government funding and operating status. This change does not affect study record details or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-16T14:23:13.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Record History shows recruitment-status updates across multiple versions: 2018-07-17, 2021-08-03, and 2025-08-21. These changes reflect shifts in the study's enrollment status.
    Difference
    0.1%
    Check dated 2025-11-02T00:56:06.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Added a government-operation notice and version bump to v3.2.0; removed reference to v3.1.0. The page now informs users about potential processing delays and where to check status, reflecting an operational update.
    Difference
    13%
    Check dated 2025-10-04T12:18:53.000Z thumbnail image

Stay in the know with updates to Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.